Zimmer Biomet Holdings revenue and financials

ZBH · NYSE · USD

$89.68−2.06%−$1.89

Close · October 6, 2026

In the fiscal year ended December 2025, Zimmer Biomet Holdings reported revenue of $8.23B (+7.20% year over year). Net income was $705.1M, a net margin of 8.6%.

Annual revenue · 2025: $8.23B
  1. $7.67B2016
  2. $7.8B2017
  3. $7.93B2018
  4. $7.98B2019
  5. $6.13B2020
  6. $6.83B2021
  7. $6.94B2022
  8. $7.39B2023
  9. $7.68B2024
  10. $8.23B2025

Fiscal year ending in December. Sources and method on the page Methodology and sources.

At a glance

Revenue growth
+7.20%
2025 vs 2024
Net income growth
−21.98%
2025 vs 2024
Net margin
8.6%
2024: 11.8%

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

ItemQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Total revenue2,1772,0872,2442,0012,0771,9092,0231,8241,9421,8891,9401,754
Cost of revenue636594796559592550575539554512531519
Gross profit1,5421,4931,4481,4421,4851,3591,4481,2861,3881,3771,4101,235
Selling, general and administrative882846839809807757703705733734683671
Research and development105103119116113111109112109108113117
Operating income391381313340404341479321402393468302
EBIT391381313340404341479321402393468302
EBITDA662651597624676595743572645631709543
Interest expense72.968.871.975.479.366.261.954.351.150.750.351.1
Pre-tax income25530197.9279225229289230302215285219
Income tax55.563.0-39.948.071.246.548.9-18.959.142.3-13556.4
Net income198238139231153182240249243172419163
Net income to common shareholders198238139231153182240249243172419163
Basic EPS1.031.220.711.170.770.921.201.231.180.842.020.78
Diluted EPS1.031.220.711.160.770.911.191.231.180.842.010.77
Average shares (basic)192195197198198199199202206205208209
Average shares (diluted)193196198199198200200203206206209210
Dividend per share0.240.240.240.240.240.240.240.240.240.240.240.24